GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocular Therapeutix Inc (FRA:0OT) » Definitions » E10

Ocular Therapeutix (FRA:0OT) E10 : €-2.09 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Ocular Therapeutix E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ocular Therapeutix's adjusted earnings per share data for the three months ended in Mar. 2024 was €-0.451. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-2.09 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-24), Ocular Therapeutix's current stock price is €5.294. Ocular Therapeutix's E10 for the quarter that ended in Mar. 2024 was €-2.09. Ocular Therapeutix's Shiller PE Ratio of today is .


Ocular Therapeutix E10 Historical Data

The historical data trend for Ocular Therapeutix's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocular Therapeutix E10 Chart

Ocular Therapeutix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -2.55 -2.33

Ocular Therapeutix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.71 -2.50 -2.44 -2.33 -2.09

Competitive Comparison of Ocular Therapeutix's E10

For the Biotechnology subindustry, Ocular Therapeutix's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocular Therapeutix's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocular Therapeutix's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ocular Therapeutix's Shiller PE Ratio falls into.



Ocular Therapeutix E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ocular Therapeutix's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.451/131.7762*131.7762
=-0.451

Current CPI (Mar. 2024) = 131.7762.

Ocular Therapeutix Quarterly Data

per share eps CPI Adj_EPS
201406 -1.546 100.560 -2.026
201409 -0.372 100.428 -0.488
201412 -0.300 99.070 -0.399
201503 -0.323 99.621 -0.427
201506 -0.401 100.684 -0.525
201509 -0.419 100.392 -0.550
201512 -0.395 99.792 -0.522
201603 -0.395 100.470 -0.518
201606 -0.409 101.688 -0.530
201609 -0.347 101.861 -0.449
201612 -0.493 101.863 -0.638
201703 -0.542 102.862 -0.694
201706 -0.570 103.349 -0.727
201709 -0.453 104.136 -0.573
201712 -0.372 104.011 -0.471
201803 -0.324 105.290 -0.406
201806 -0.317 106.317 -0.393
201809 -0.326 106.507 -0.403
201812 -0.369 105.998 -0.459
201903 -0.398 107.251 -0.489
201906 -0.504 108.070 -0.615
201909 -0.409 108.329 -0.498
201912 -0.477 108.420 -0.580
202003 -0.371 108.902 -0.449
202006 -0.568 108.767 -0.688
202009 -0.178 109.815 -0.214
202012 -0.995 109.897 -1.193
202103 -0.202 111.754 -0.238
202106 -0.208 114.631 -0.239
202109 -0.196 115.734 -0.223
202112 -0.204 117.630 -0.229
202203 -0.200 121.301 -0.217
202206 -0.237 125.017 -0.250
202209 -0.313 125.227 -0.329
202212 -0.227 125.222 -0.239
202303 -0.364 127.348 -0.377
202306 -0.240 128.729 -0.246
202309 -0.234 129.860 -0.237
202312 -0.321 129.419 -0.327
202403 -0.451 131.776 -0.451

Add all the adjusted EPS together and divide 10 will get our e10.


Ocular Therapeutix  (FRA:0OT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ocular Therapeutix E10 Related Terms

Thank you for viewing the detailed overview of Ocular Therapeutix's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Ocular Therapeutix (FRA:0OT) Business Description

Traded in Other Exchanges
Address
24 Crosby Drive, Bedford, MA, USA, 01730
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Ocular Therapeutix (FRA:0OT) Headlines

No Headlines